Coromandel International (COROMANDEL) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
13 Jun, 2025Company overview and history
Flagship of Murugappa Group, contributing 38% of group revenue with $9.3B turnover and $0.9B net profit; operates 29 businesses and 98 manufacturing locations.
Over a century in agri-business, with major milestones including backward integration, global sourcing, and expansion into agrochemicals and retail.
Delivers integrated farm solutions to 20 million farmers via 13,000 channel partners and 800+ retail stores across India.
Financial performance and shareholder returns
Revenue grew from ₹10,053 Cr (FY14) to ₹29,628 Cr (FY23), with PAT rising from ₹365 Cr to ₹2,013 Cr; 8% CAGR in revenue and 16% in PAT.
5-year annualized stock return of 23% vs Nifty 50's 15%; market cap at ₹526B as of Nov 2024.
Maintains a strong balance sheet with zero net debt and AAA credit ratings.
Consistent dividend payouts and robust cash generation.
Business segments and operations
Largest private NPK and SSP fertilizer producer, with 3.5M ton NPK and 1M ton SSP capacity; strong presence in South India.
Crop protection business is the 6th largest in India, with 20 technicals, 1,000+ global registrations, and exports to 80 countries.
Specialty nutrients and bioproducts divisions lead in organic and neem-based products, with significant R&D and export presence.
Retail network is India's largest agri-retail chain, directly connecting with 3.3 million farmers and achieving 98% store profitability.
Latest events from Coromandel International
- Revenue up 16% YoY, profit down 24%, with CPC and specialty growth and key capital actions.COROMANDEL
Q1 26/27 - Record revenue and EBITDA growth, but PAT fell and a Rs. 2 dividend was declared.COROMANDEL
Q4 25/26 - Q3 revenue up 27% to ₹8,779.45 crore, net profit ₹652.76 crore, ₹9/share dividend declared.COROMANDEL
Q3 25/26 - Q2 FY26 net profit rose to ₹821.01 crore on revenue of ₹9,654 crore, driven by segment growth and NACL acquisition.COROMANDEL
Q2 25/26 - Revenue up 49% and PAT up 62% year-over-year, with strong segment growth and NACL deal pending.COROMANDEL
Q1 25/26 - Q2 FY25 revenue up 6% YoY, but profit and margins declined amid robust segment growth.COROMANDEL
Q2 24/25 - Q1 FY25 saw lower revenue and profit, but strong innovation and strategic investments continued.COROMANDEL
Q1 24/25 - Strong revenue and profit growth, major acquisitions, and robust dividends defined FY25.COROMANDEL
Q4 24/25 - Q3 profit more than doubled on strong nutrient growth; interim dividend and expansion announced.COROMANDEL
Q3 24/25